|
|
|||||
|
|
Prescription Diet Drugs* *Please note that the information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician. Always consult your physician for medical advice, Diet Drug advice, and before starting any weight loss program. Overview | Betahistine | Didrex | Diethylproprion | Leptin | Meridia Phendimetrazine | Phentermine | Rimonabant | Xenical and Alli
The market for prescription diet drugs has been bumpy, characterized by major product withdrawals, some nasty side effects, and moderate weight loss. The “magic pill” everyone is hoping for is still not here. Only two drugs (orlistat and sibutramine) have been approved for the long-term treatment of obesity.
Representatives of the pharmaceutical industry estimate that slightly more than two dozen obesity drugs are currently undergoing clinical trials. Meanwhile, another 32 experimental medications are in early-stage development, and six existing drugs approved for diabetes are being cross-tested for their effectiveness at reducing weight in overweight patients.
Currently there are more than a dozen new drugs for treating obesity either in or about to begin human clinical trials and there are 5 new drugs in clinical trials for diabetes, which may also produce weight loss. In addition, there are also at least 20 other drugs which impact feeding, appetite, metabolic rate, or weight regulation that are in pre-clinical or animal testing.
Obesity costs America a staggering $100+ billion in health care costs and weight-loss products and programs, according to the U.S. Surgeon General. As the rate of obesity in America is growing, there has been a fundamental shift in how obesity is viewed - as a disease rather than simply poor lifestyle habits.
|
|
|||
|
|||||
email this site to a
friend